Effects and mechanisms of berberine in diabetes treatment

[1]  Jin-Yuarn Lin,et al.  Protective effect of berberine on serum glucose levels in non-obese diabetic mice. , 2012, International immunopharmacology.

[2]  Qiang Li,et al.  Berberine alleviates ischemic arrhythmias via recovering depressed I(to) and I(Ca) currents in diabetic rats. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  Xiaojun Meng,et al.  [Research on therapeutic effect and hemorrheology change of berberine in new diagnosed patients with type 2 diabetes combining nonalcoholic fatty liver disease]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[4]  Jianan Wang,et al.  Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  Christina Plaisier,et al.  Berberine acutely activates the glucose transport activity of GLUT1. , 2011, Biochimie.

[6]  Jin-Yuarn Lin,et al.  Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice. , 2011, Journal of agricultural and food chemistry.

[7]  Junling Han,et al.  Modulating gut microbiota as an anti-diabetic mechanism of berberine , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[8]  P. Bhutada,et al.  Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes , 2011, Behavioural Brain Research.

[9]  Hua Zhu,et al.  Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters. , 2011, Biological & pharmaceutical bulletin.

[10]  Jiyin Zhou,et al.  Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. , 2011, Fitoterapia.

[11]  Jianping Ye,et al.  Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis , 2011, PloS one.

[12]  C. Beaurepaire,et al.  Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. , 2011, Metabolism: clinical and experimental.

[13]  Qiang Li,et al.  Berberine elicits anti‐arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model , 2011, Phytotherapy research : PTR.

[14]  Shiwen Zhou,et al.  Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes. , 2010, European journal of pharmacology.

[15]  M. Zeitz,et al.  TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signaling , 2010, Journal of Cell Science.

[16]  T. Egawa,et al.  Berberine-induced activation of 5'-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles. , 2010, Metabolism: clinical and experimental.

[17]  Suowen Xu,et al.  Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway. , 2010, Archives of biochemistry and biophysics.

[18]  M. Gu,et al.  8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models. , 2010, Bioorganic & medicinal chemistry.

[19]  Zhaoyong Hu,et al.  Atrogin-1 Affects Muscle Protein Synthesis and Degradation When Energy Metabolism Is Impaired by the Antidiabetes Drug Berberine , 2010, Diabetes.

[20]  Chih-Hsin Tang,et al.  Berberine suppresses neuroinflammatory responses through AMP‐activated protein kinase activation in BV‐2 microglia , 2010, Journal of cellular biochemistry.

[21]  Xiao-dong Liu,et al.  Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  Wei-Jia Kong,et al.  Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. , 2010, Metabolism: clinical and experimental.

[23]  Jing Li,et al.  Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. , 2009, European journal of pharmacology.

[24]  Guoliang Cui,et al.  Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice* , 2009, The Journal of Biological Chemistry.

[25]  W. Jia,et al.  [Study on effects of baicalin, berberine and Astragalus polysaccharides and their combinative effects on aldose reductase in vitro]. , 2009, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[26]  A. Xu,et al.  Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. , 2009, Cardiovascular research.

[27]  J. B. Kim,et al.  Berberine suppresses proinflammatory responses through AMPK activation in macrophages. , 2009, American journal of physiology. Endocrinology and metabolism.

[28]  M. Lane,et al.  Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. , 2009, American journal of physiology. Endocrinology and metabolism.

[29]  Kebin Zhang,et al.  Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. , 2009, European journal of pharmacology.

[30]  Peiqing Liu,et al.  Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition , 2009, Molecular and Cellular Biochemistry.

[31]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[32]  Wei Zhang,et al.  Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. , 2008, Chinese medical journal.

[33]  Xiao Wang,et al.  Berberine acutely inhibits insulin secretion from beta-cells through 3',5'-cyclic adenosine 5'-monophosphate signaling pathway. , 2008, Endocrinology.

[34]  F. Lu,et al.  [Effects of berberine on expression of hepatocyte nuclear factor 4alpha and glucokinase activity in mouse primary hepatocytes]. , 2008, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[35]  Shufeng Zhou,et al.  Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. , 2008, Archives of biochemistry and biophysics.

[36]  G. Ning,et al.  Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. , 2008, The Journal of clinical endocrinology and metabolism.

[37]  Le Zhang,et al.  Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. , 2008, Biological & pharmaceutical bulletin.

[38]  Jianping Ye,et al.  Efficacy of berberine in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[39]  Shousi Lu,et al.  Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats. , 2008, Die Pharmazie.

[40]  Weihua Liu,et al.  Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. , 2008, Chinese medical journal.

[41]  D. James,et al.  Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I , 2008, Diabetes.

[42]  Hyun-Joung Lim,et al.  Berberine-induced LDLR up-regulation involves JNK pathway. , 2007, Biochemical and biophysical research communications.

[43]  P. Bénit,et al.  Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes , 2007, Cell.

[44]  C. Hyun,et al.  Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. , 2007, Biological & pharmaceutical bulletin.

[45]  Xiao Wang,et al.  Berberine stimulates glucose transport through a mechanism distinct from insulin. , 2007, Metabolism: clinical and experimental.

[46]  L. Rovati,et al.  Eulipidemic Effects of Berberine Administered Alone or in Combination with Other Natural Cholesterol-lowering Agents , 2007, Arzneimittelforschung.

[47]  Ji-won Park,et al.  Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte , 2006, Experimental & Molecular Medicine.

[48]  Wei Wei,et al.  Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. , 2006, Journal of ethnopharmacology.

[49]  M. Gu,et al.  Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. , 2006, Biochimica et biophysica acta.

[50]  Yuebo Zhang,et al.  Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway , 2006 .

[51]  D. James,et al.  Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States , 2006, Diabetes.

[52]  J. Brusq,et al.  Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine Published, JLR Papers in Press, February 28, 2006. , 2006, Journal of Lipid Research.

[53]  Hyun-Joung Lim,et al.  Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model. , 2006, Atherosclerosis.

[54]  C. Ting,et al.  Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. , 2006, Biochemical pharmacology.

[55]  Jingwen Liu,et al.  Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[56]  J. Castillo,et al.  LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation. , 2005, Analytical biochemistry.

[57]  Sunmin Park,et al.  Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma. , 2005, Biological & pharmaceutical bulletin.

[58]  Satoru Inaba,et al.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins , 2004, Nature Medicine.

[59]  Weihua Chen,et al.  [Effect of Astragalus polysaccharides and berberine on carbohydrate metabolism and cell differentiation in 3T3-L1 adipocytes]. , 2004, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[60]  D. Hardie,et al.  AMP-Activated Protein Kinase: A Master Switch in Glucose and Lipid Metabolism , 2004, Reviews in Endocrine and Metabolic Disorders.

[61]  F. Lu,et al.  Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. , 2004, Acta pharmacologica Sinica.

[62]  J. Arrabaça,et al.  Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. , 2003, Toxicology letters.

[63]  Guang-Ji Wang,et al.  [Inhibitory action of berberine on glucose absorption]. , 2003, Yao xue xue bao = Acta pharmaceutica Sinica.

[64]  J. P. Fawcett,et al.  The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. , 2003, Planta medica.

[65]  Xiao Wang,et al.  [Effect of berberine on the differentiation of adipocyte]. , 2003, Zhonghua yi xue za zhi.

[66]  Feng-ying Li,et al.  Effects of berberine on glucose metabolism in vitro. , 2002, Metabolism: clinical and experimental.

[67]  R. Tan,et al.  Monoamine Oxidase Inhibitors from Rhizoma of Coptis chinensis , 2001, Planta medica.

[68]  Ni Yx.  Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research , 1988 .

[69]  V. Mikes,et al.  Interaction of fluorescent berberine alkyl derivatives with respiratory chain of rat liver mitochondria , 1985, Journal of bioenergetics and biomembranes.

[70]  V. Mikes,et al.  Berberine derivatives as cationic fluorescent probes for the investigation of the energized state of mitochondria. , 1983, Biochimica et biophysica acta.

[71]  Hua Zhu,et al.  Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRα and PPARα transcriptional programs. , 2010, Endocrine journal.

[72]  Zhou Shi-wen.  Effect of berberine on CDK9 and cyclin T1 expression in skeletal muscle of diabetic rats induced by streptozotocin and a high-carbohydrate/high-fat diet , 2008 .

[73]  Jianping Ye,et al.  Berberine improves glucose metabolism through induction of glycolysis. , 2008, American journal of physiology. Endocrinology and metabolism.

[74]  Jiyin Zhou,et al.  Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism , 2007 .

[75]  Yuebo Zhang,et al.  Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. , 2006, Biochemical and biophysical research communications.

[76]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[77]  C. Ming.  Effects of berberine on glucose and lipid metabolism in animal experiment , 2004 .

[78]  Y. Ying.  Effects of Berberine on Lipid Metabolism in Rats , 2003 .

[79]  M. D. Faddeeva,et al.  [Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their derivative drugs]. , 2003, Tsitologiia.

[80]  Y. Ni.  [Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research]. , 1988, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine.